10x Genomics, Inc. TXG Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $150.84M-9.1% | $166.03M+11.4% | $149M-13.8% | $172.91M+11.6% | $154.88M-6.1% | ||
| $44.67M-15.7% | $52.99M+8.8% | $48.7M+1.8% | $47.82M-3.3% | $49.44M-8.6% | ||
| $106.18M-6.1% | $113.05M+12.7% | $100.31M-19.8% | $125.08M+18.6% | $105.45M-5.0% | ||
| 70.4%+2.3pp | 68.1%+0.8pp | 67.3%-5.0pp | 72.3%+4.3pp | 68.1%+0.8pp | ||
| $56.85M+1.6% | $55.97M-2.1% | $57.19M-6.6% | $61.22M-4.7% | $64.25M-4.1% | ||
| $66.38M-13.4% | $76.62M+1.7% | $75.36M+1.2% | $74.43M-17.0% | $89.73M-4.4% | ||
| $123.22M-7.1% | $132.59M0.0% | $132.55M+39.6% | $94.96M-34.4% | $144.77M-10.0% | ||
| -$17.05M+12.8% | -$19.54M+39.4% | -$32.24M-207% | $30.13M+177% | -$39.33M+21.1% | ||
| -11.3%+0.5pp | -11.8%+9.9pp | -21.6%-39.1pp | 17.4%+42.8pp | -25.4%+4.8pp | ||
| $4.2M-3.4% | $4.35M+7.7% | $4.04M-41.2% | $6.87M+18.0% | $5.82M+299% | ||
| -$12.85M+15.4% | -$15.19M+46.1% | -$28.21M-176% | $37M+210% | -$33.51M+30.7% | ||
| $623K-41.2% | $1.06M+244% | -$733K-130% | $2.46M+189% | $852K+31.5% | ||
| -$13.47M+17.1% | -$16.25M+40.8% | -$27.47M-180% | $34.54M+201% | -$34.36M+29.9% | ||
| -8.9%+0.9pp | -9.8%+8.6pp | -18.4%-38.4pp | 20%+42.2pp | -22.2%+7.5pp | ||
| -$0.10+23.1% | -$0.13+40.9% | -$0.22-179% | $0.28+200% | -$0.28+31.7% | ||
| -$7.09M+25.2% | -$9.48M+56.8% | -$21.95M-158% | $37.94M+221% | -$31.31M+23.8% | ||
| -4.7%+1.0pp | -5.7%+9.0pp | -14.7%-36.7pp | 21.9%+42.2pp | -20.2%+4.7pp | ||
| -$17.05M+12.8% | -$19.54M+39.4% | -$32.24M-207% | $30.13M+177% | -$39.33M+21.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are 10x Genomics, Inc.'s profit margins?
- Gross margin is 69.6% and operating margin is -6.1%, with a -3.5% net margin.
- Where does 10x Genomics, Inc.'s income statement data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.